Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers

Autor: Borcoman, Edith, Lalanne, Ana, Delord, Jean-Pierre, Cassier, Philippe A., Rolland, Frédéric, Salas, Sébastien, Limacher, Jean-Marc, Capitain, Olivier, Lantz, Olivier, Ekwegbara, Christina, Jeannot, Emmanuelle, Cyrta, Joanna, Tran-Perennou, Carine, Castel-Ajgal, Zahra, Marret, Grégoire, Piaggio, Eliane, Brandely, Maud, Tavernaro, Annette, Makhloufi, Hakim, Bendjama, Kaidre, Le Tourneau, Christophe
Zdroj: In European Journal of Cancer September 2023 191
Databáze: ScienceDirect
Externí odkaz: